119 related articles for article (PubMed ID: 24195979)
21. Prognostic Significances of NEDD-9 and FOXL-1 Expression in Intestinal Type Gastric Carcinoma: an Immunohistochemical Study.
Elaidy NF; Harb OA; Mohamed AM; Hemeda R; Taha HF; Samir A; Elsayed AM; Osman G; Hendawy EIE
J Gastrointest Cancer; 2021 Jun; 52(2):728-737. PubMed ID: 32794109
[TBL] [Abstract][Full Text] [Related]
22. [Analysis of clinicopathologic characteristics of gastric cancer patients undergoing gastrectomy based on a single-center gastric cancer database with above 10 000 cases].
Liang WQ; Xi HQ; Qiao S; Cui JX; Zhang KC; Gao YH; Song YN; Zhang L; Luo H; Wei B; Xue WG; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1051-1058. PubMed ID: 33212553
[No Abstract] [Full Text] [Related]
23. Real-world Treatment Patterns and Clinical Outcomes Across Lines of Therapy in Patients With Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer.
Le DT; Ott PA; Korytowsky B; Le H; Le TK; Zhang Y; Maglinte GA; Abraham P; Patel D; Shangguan T; Chau I
Clin Colorectal Cancer; 2020 Mar; 19(1):32-38.e3. PubMed ID: 31813769
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological profile and long-term outcome in young adults with gastric cancer: multicenter evaluation of 214 patients.
Kulig J; Popiela T; Kolodziejczyk P; Sierzega M; Jedrys J; Szczepanik AM;
Langenbecks Arch Surg; 2008 Jan; 393(1):37-43. PubMed ID: 17618451
[TBL] [Abstract][Full Text] [Related]
25. Superiority of log odds of positive lymph nodes (LODDS) for prognostic prediction after gastric cancer surgery: a multi-institutional analysis of 7620 patients in China.
Gu P; Deng J; Sun Z; Wang Z; Wang W; Liang H; Xu H; Zhou Z
Surg Today; 2021 Jan; 51(1):101-110. PubMed ID: 32754844
[TBL] [Abstract][Full Text] [Related]
26. Gastric Carcinomas in Young (Younger than 40 Years) Chinese Patients: Clinicopathology, Family History, and Postresection Survival.
Zhou F; Shi J; Fang C; Zou X; Huang Q
Medicine (Baltimore); 2016 Mar; 95(9):e2873. PubMed ID: 26945372
[TBL] [Abstract][Full Text] [Related]
27. Gastric adenocarcinoma in patients 40 years of age or younger.
Theuer CP; de Virgilio C; Keese G; French S; Arnell T; Tolmos J; Klein S; Powers W; Oh T; Stabile BE
Am J Surg; 1996 Nov; 172(5):473-6; discussion 476-7. PubMed ID: 8942547
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic study of advanced gastric cancer without serosal invasion in young and old patients.
Wang JY; Hsieh JS; Huang CJ; Huang YS; Huang TJ
J Surg Oncol; 1996 Sep; 63(1):36-40. PubMed ID: 8841464
[TBL] [Abstract][Full Text] [Related]
29. OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long-term Follow-up Study of 7436 Patients.
Rugge M; Genta RM; Fassan M; Valentini E; Coati I; Guzzinati S; Savarino E; Zorzi M; Farinati F; Malfertheiner P
Am J Gastroenterol; 2018 Nov; 113(11):1621-1628. PubMed ID: 30333540
[TBL] [Abstract][Full Text] [Related]
30. [Clinicopathologic characteristics and prognosis analysis of 90 young patients with gastric cancer].
Zhou R; Zhao J; Shu P; Wang H; Qin J; Sun Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Nov; 20(11):1288-1292. PubMed ID: 29178101
[TBL] [Abstract][Full Text] [Related]
31. [Clinicopathologic characteristics and prognostic factors of gastric cancer in the elderly patients over 75 years].
Gao H; Lan X; Li S; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 May; 19(5):522-5. PubMed ID: 27215518
[TBL] [Abstract][Full Text] [Related]
32. High-level FGFR2 amplification is associated with poor prognosis and Lower response to chemotherapy in gastric cancers.
Hur JY; Chao J; Kim K; Kim ST; Kim KM; Klempner SJ; Lee J
Pathol Res Pract; 2020 Apr; 216(4):152878. PubMed ID: 32089408
[TBL] [Abstract][Full Text] [Related]
33. Elastic staining-a rejuvenated method to reassess prognosis and serosal invasion in patients with pT3N0M0 gastric cancer.
Lei G; Yang H; Hong T; Zhou C; Li J; Liu W; Hu J; Zeng L; Chen G; Chen Q; Zhang Y; Yang N
Hum Pathol; 2017 Jul; 65():79-84. PubMed ID: 28504204
[TBL] [Abstract][Full Text] [Related]
34. Stage-specific difference in timing and pattern of initial recurrence after curative surgery for gastric cancer.
Kim JH; Lee HH; Seo HS; Jung YJ; Park CH
Surg Oncol; 2019 Sep; 30():81-86. PubMed ID: 31500791
[TBL] [Abstract][Full Text] [Related]
35. Impaired Gastric Cancer Survival in Patients with Inflammatory Bowel Disease.
Nissen LH; Assendorp EL; van der Post RS; Derikx LA; de Jong DJ; Kievit W; Pierik M; van den Heuvel T; Verhoeven R; Overbeek LI; Hoentjen F; Nagtegaal ID
J Gastrointestin Liver Dis; 2016 Dec; 25(4):431-440. PubMed ID: 27981298
[TBL] [Abstract][Full Text] [Related]
36. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer.
Karabulut M; Alis H; Afsar CU; Karabulut S; Kocatas A; Oguz H; Aykan NF
Biomed Pharmacother; 2015 Jul; 73():140-6. PubMed ID: 26211595
[TBL] [Abstract][Full Text] [Related]
37. Multiple primary malignancies involving primary sporadic colorectal cancer in Japan: incidence of gastric cancer with colorectal cancer patients may be higher than previously recognized.
Kato T; Suzuki K; Muto Y; Sasaki J; Tsujinaka S; Kawamura YJ; Noda H; Horie H; Konishi F; Rikiyama T
World J Surg Oncol; 2015 Feb; 13():23. PubMed ID: 25889477
[TBL] [Abstract][Full Text] [Related]
38. [Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach].
Dong R; Zhang Z; Zhou Y; Hua Y; Guo J
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):185-189. PubMed ID: 29492918
[TBL] [Abstract][Full Text] [Related]
39. [Clinicopathologic features of gastric adenocarcinoma based on the revised Lauren's classification].
Li Y; Xue XW; Luo YF; Wu HW; Chen J; Zhou WX
Zhonghua Bing Li Xue Za Zhi; 2018 Jul; 47(7):486-491. PubMed ID: 29996311
[No Abstract] [Full Text] [Related]
40. Gastric cancer in young patients.
Eguchi T; Takahashi Y; Yamagata M; Kasahara M; Fujii M
J Am Coll Surg; 1999 Jan; 188(1):22-6. PubMed ID: 9915238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
